Lemborexant: A Dual Orexin Receptor Antagonist with Favorable Safety and Pharmacokinetic Profiles
Lemborexant promotes sleep by targeting orexin receptors, with good tolerability in adults. Caution advised for respiratory issues and potential drug interactions require careful management.
Mar 29，2024
The synthesis method of Lemborexant
Lemborexant is an orally administered dual orexin receptor (OXR) antagonist developed by Eisai for the treatment of adults with insomnia.
Jan 8，2024
Lemborexant:Pharmacodynamics,Mechanism,Side Effects
Lemborexant is used to treat insomnia (difficulty falling asleep or staying asleep). Lemborexant belongs to a class of medications called hypnotics. It works by slowing activity in the brain to allow sleep.
Jan 5，2023
